News & Events
Read our latest research news, explore upcoming events and find resources describing our mission and programs.
Latest News
NCATS Stories
Comprehensive Testing Confirms Quality of Tox21 Library’s Chemical Compounds
January 14, 2025 - NCATS News
- Assay Development and Screening Technology (ADST)
- Our Impact on Tools and Technologies
- Toxicology in the 21st Century (Tox21)
NCATS researchers assessed how well the Tox21 library’s chemicals hold up in real-world research conditions to ensure scientifically valid outcomes.
Read ArticleNIH More Than Triples Its Investments in Digital Health Technology Research
January 3, 2025 - NCATS News
- Clinical and Translational Science Awards (CTSA) Program
- Informatics (IFX)
- Our Impact on Tools and Technologies
A new study by NCATS researchers showed that NIH has more than tripled its funding for research on digital health technologies in the last nine years.
Read ArticlePartner & Grantee News
White House Awards UB Professor the Nation’s Highest Honor in STEM Mentoring
January 16, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Drug in Clinical Trials for Breast Cancer Could Also Treat Some Blood Cancers
January 13, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Autoimmune Skin Condition Linked to Higher Risk of Heart Disease
January 13, 2025 - Grantee/Partner News
- Clinical and Translational Science Awards (CTSA) Program
Upcoming Events
NIH Rare Pair: Rare Disease Treatments Partnering Workshop
July 24, 2025 - July 25, 2025 - Workshop
Location: Mass General Brigham, Boston, Massachusetts
Join us for the NIH Rare Pair: Rare Disease Treatments Partnering Workshop, a pivotal event bringing together key contributors in the rare diseases ecosystem. Hosted by the National Institutes of Health (NIH), this workshop will take place July 24–25, 2025, at Mass General Brigham in Boston, Massachusetts.
This unique gathering will explore the rare diseases commercialization landscape from the diverse perspectives of industry leaders, private investors, government funders and patient advocacy organizations. Attendees will engage in dynamic panels and discussions addressing the challenges, opportunities and critical areas of interest in developing novel therapies for rare diseases.
Key highlights of the workshop include the following:
- Interactive Panels and Discussions: Gain insights into overcoming barriers and maximizing opportunities in the rare diseases treatment space.
- Rare Diseases Therapy Pitch Session: Listen to innovative NIH-supported investigators presenting cutting-edge treatments for rare diseases.
- Networking Opportunities: Build meaningful connections with researchers, investors and strategic partners driving advances in rare disease therapeutics.
Whether you’re a researcher, investor, advocate or industry professional, this workshop offers a unique opportunity to collaborate and accelerate the development of groundbreaking treatments for rare diseases.
Save the date and be part of the conversation that transforms ideas into treatments for patients with rare diseases.
Registration information and agenda will be coming soon.
Publications
Browse a listing of peer-reviewed scientific publications that feature research supported by NCATS programs and initiatives.
Effectiveness of Ventilation via an Endotracheal Tube in Pharynx Versus a Facemask in Patients With Potentially Difficult Airway: A Randomized, Crossover, and Blind Trial
Clinical and Translational Science Awards (CTSA) Program - February 1, 2025 - Anesthesia & Analgesia
Read PublicationWeight and Blood-Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients
Clinical and Translational Science Awards (CTSA) Program - February 1, 2025 - Journal of Cachexia, Sarcopenia and Muscle
Read PublicationBiomarker Investigation Using Multiple Brain Measures From MRI Through Explainable Artificial Intelligence in Alzheimer’s Disease Classification
Clinical and Translational Science Awards (CTSA) Program - January 17, 2025 - Bioengineering
Read PublicationMicroRNA Expression Profile in Acute Ischemic Stroke
Clinical and Translational Science Awards (CTSA) Program - January 17, 2025 - International Journal of Molecular Sciences
Read PublicationA Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART® Molecule for Treatment of Solid Tumors
Assay Guidance Manual (AGM) - January 17, 2025 - Antibodies
Read PublicationRSK1 Is an Exploitable Dependency in Myeloproliferative Neoplasms and Secondary Acute Myeloid Leukemia
Clinical and Translational Science Awards (CTSA) Program - January 16, 2025 - Nature Communications
Read PublicationOptimization of a Micro-Scale Air–Liquid-Interface Model of Human Proximal Airway Epithelium for Moderate Throughput Drug Screening for SARS-CoV-2
Clinical and Translational Science Awards (CTSA) Program - January 16, 2025 - Respiratory Research
Read PublicationUltrasensitive Detection of Six Sepsis-Associated Proteins in Neonatal Saliva
Clinical and Translational Science Awards (CTSA) Program - January 16, 2025 - npj Biosensing
Read PublicationTherapeutic Plasma Exchange Accelerates Immune Cell Recovery in Severe COVID-19
Clinical and Translational Science Awards (CTSA) Program - January 16, 2025 - Frontiers in Immunology
Read PublicationMenopause-Induced 17β-Estradiol and Progesterone Loss Increases Senescence Markers, Matrix Disassembly and Degeneration in Mouse Cartilage
Clinical and Translational Science Awards (CTSA) Program - January 16, 2025 - Nature Aging
Read Publication